Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that more research is needed to fully understand the causes of PCOS.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The PP2A-B55α protein is essential for brain and skin development in embryos.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Glioblastoma cells can make androgens, which might help the tumor grow.

Finger length ratio may indicate male hair loss.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

New treatments for hair loss are being developed using molecular biology.